| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |